<DOC>
	<DOCNO>NCT02223520</DOCNO>
	<brief_summary>This trial test hypothesis treat parent neonates require NICU care intranasal mupirocin topical chlorhexidine bath reduce spread S. aureus parent neonate .</brief_summary>
	<brief_title>Treating Parents Reduce NICU Transmission Staphylococcus Aureus Trial</brief_title>
	<detailed_description>The TREAT PARENTS Trial , Treating Parents Reduce NICU Transmission S. aureus , placebo-controlled , double-masked , randomized clinical trial test hypothesis treatment S. aureus colonize parent intranasal mupirocin topical chlorhexidine gluconate antisepsis decrease neonatal S. aureus acquisition . All neonate admit Johns Hopkins Hospital Johns Hopkins Bayview Medical Center NICUs pre-screened parent approach enrollment study . After consent baseline screening , 400 neonate-parent pair randomize ; neonate parent colonize S. aureus randomize . Parents receive 5 day treatment intranasal mupirocin plus topical chlorhexidine gluconate antisepsis placebo . After recruitment informed consent , parent undergo pre-randomization screening . If parent screen negative S. aureus colonization , neonate ineligible randomization parent inform colonized time S. aureus . If either parent screen positive S. aureus , parent pair eligible randomization one two possible mask treatment arm . The neonate-parent `` pair '' unit randomization parent allocate group consent . After baseline neonate test S. aureus colonization , repeat test perform every 7 day neonate neonate acquires S. aureus colonization discharge NICU .</detailed_description>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<mesh_term>Mupirocin</mesh_term>
	<criteria>Neonate never clinical surveillance culture grow S. aureus Neonate transfer another hospital admit home admission screen culture S. aureus colonization negative ( admission culture perform , perform part prerandomization screen process ) Parent ( ) ( ) able visit child bedside Parent ( ) test positive S. aureus screen Neonate anticipate stay longer 5 day NICU ( estimate stay unclear , parent screen S. aureus colonization decision randomize delayed hospital day 3 4 reassessment anticipate stay ) . Parents ( ) willing randomize No document report allergy agent use either treatment regimen Able perform write informed consent Allergies agent use either treatment regimen Neonate prior clinical surveillance culture grow S. aureus Neonate admit NICU home great 7 day age Neonate admit NICU another hospital great 7 day age Neonate ward State Not able provide write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Staphylococcus aureus</keyword>
	<keyword>Infection</keyword>
	<keyword>Colonization</keyword>
	<keyword>Transmission</keyword>
	<keyword>Neonate</keyword>
</DOC>